Citizens reiterates Bicara Therapeutics stock rating on trial progress — See source for full details.
$BCAX
Price history, market instrument context, member research, and related headlines in one place.
BCAX key statistics
NasdaqGMUSD
52-week range
$13.7021%$30.99
Latest session $17.12–$17.68Bicara Therapeutics Inc. (BCAX) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $17.34, up $0.00 (0.00%) from the previous close of $17.34. It has traded between $17.12 and $17.68 in the latest session. Over the past year it has ranged from $13.70 to $30.99, leaving it in the lower quarter of its 52-week range (21%). Reported volume for the session was 1.4M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Bicara Therapeutics Inc. Common Stock Q2 2026 Earnings Call Summary — See source for full details.
Bicara Therapeutics announces CEO transition, CFO appointment — See source for full details.
Loading $BCAX research…